Amneal Pharmaceuticals, Inc Class A Common Stock Financials

Values in thousands	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Revenue	$724,508	$695,420	$730,518	$702,468
Gross Profit	286,253	255,891	262,873	269,558
EBITDA	176,925	154,584	112,473	139,895
EBIT	116,812	94,425	46,343	80,934
Net Income	22,417	12,195	-31,081	-156
Net Change In Cash	724,508	695,420	730,518	702,468
Free Cash Flow	57,317	-10,914	95,014	121,062
Cash	81,186	59,187	110,552	74,006
Basic Shares	322,363	323,961	309,850	309,647

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,793,957	$2,393,607	$2,212,304	$2,093,669
Gross Profit	1,020,438	820,565	791,461	783,949
EBITDA	439,773	399,759	150,425	401,097
EBIT	203,582	170,359	-89,750	167,691
Net Income	-116,886	-83,993	-129,986	10,624
Net Change In Cash	2,793,957	2,393,607	2,212,304	2,093,669
Cost of Revenue			-215,829	-90,484
Free Cash Flow	243,175	276,388	-25,495	189,181
Cash	110,552	91,542	25,976	247,790
Basic Shares	308,978	176,136	150,944	151,821